CTC Capital Management’s Medtronic MDT Stock Holding History

CTC Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,200	Closed	-$249K	–	110
2022 Q4	$249K	Buy	+3,200	New	+$259K	0.29%	72

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CTC Capital Management's MDT Position: Q1 2023 in Review

CTC Capital Management sold out of Medtronic (MDT) in Q1 2023, closing a stake of 3,200 shares — an estimated $249K sold.

CTC Capital Management first reported a position in MDT in Q4 2022 and held it in 1 quarter. The position peaked at $249K in Q4 2022. 1,990 funds tracked by Wall St. Rank hold MDT as of Q1 2023.

CTC Capital Management reported no remaining Medtronic position as of Q1 2023 after selling out during the quarter.
CTC Capital Management sold 3,200 Medtronic shares in Q1 2023, an estimated $249K.
CTC Capital Management first reported a position in Medtronic in Q4 2022 and held it in 1 quarter.
CTC Capital Management's Medtronic position peaked at $249K in Q4 2022.
1,990 funds tracked by Wall St. Rank held Medtronic as of Q1 2023.

Based on CTC Capital Management's 13F filing for Q1 2023, filed 5 May 2023.